|
1
|
Heinegård D: Fell-Muir Lecture:
Proteoglycans and more-from molecules to biology. Int J Exp Pathol.
90:575–586. 2009. View Article : Google Scholar
|
|
2
|
Iozzo RV and Schaefer L: Proteoglycan form
and function: A comprehensive nomenclature of proteoglycans. Matrix
Biol. 42:11–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wendel M, Sommarin Y and Heinegård D: Bone
matrix proteins: Isolation and characterization of a novel
cell-binding keratan sulfate proteoglycan (osteoadherin) from
bovine bone. J Cell Biol. 141:839–847. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sommarin Y, Wendel M, Shen Z, Hellman U
and Heinegârd D: Osteoadherin, a cell-binding keratan sulfate
proteoglycan in bone, belongs to the family of leucine-rich repeat
proteins of the extracellular matrix. J Biol Chem. 273:16723–16729.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buchaille R, Couble ML, Magloire H and
Bleicher F: Expression of the small leucine-rich proteoglycan
osteoadherin/osteo-modulin in human dental pulp and developing rat
teeth. Bone. 27:265–270. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nikdin H, Olsson ML, Hultenby K and Sugars
RV: Osteoadherin accumulates in the predentin towards the
mineralization front in the developing tooth. PLoS One.
7:e315252012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sjöberg AP, Manderson GA, Mörgelin M, Day
AJ, Heinegård D and Blom AM: Short leucine-rich glycoproteins of
the extracellular matrix display diverse patterns of complement
interaction and activation. Mol Immunol. 46:830–839. 2009.
View Article : Google Scholar :
|
|
8
|
Kalamajski S and Oldberg A: The role of
small leucine-rich proteoglycans in collagen fibrillogenesis.
Matrix Biol. 29:248–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schaefer L and Iozzo RV: Biological
functions of the small leucine-rich proteoglycans: From genetics to
signal transduction. J Biol Chem. 283:21305–21309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tillgren V, Onnerfjord P, Haglund L and
Heinegård D: The tyrosine sulfate-rich domains of the LRR proteins
fibromodulin and osteoadherin bind motifs of basic clusters in a
variety of heparin-binding proteins, including bioactive factors. J
Biol Chem. 284:28543–28553. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rehn AP, Cerny R, Sugars RV, Kaukua N and
Wendel M: Osteoadherin is upregulated by mature osteoblasts and
enhances their in vitro differentiation and mineralization. Calcif
Tissue Int. 82:454–464. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Canalis E, Economides AN and Gazzerro E:
Bone morphogenetic proteins, their antagonists, and the skeleton.
Endocr Rev. 24:218–235. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen G, Deng C and Li YP: TGF-β and BMP
signaling in osteoblast differentiation and bone formation. Int J
Biol Sci. 8:272–288. 2012. View Article : Google Scholar :
|
|
14
|
Katagiri T and Tsukamoto S: The unique
activity of bone morphogenetic proteins in bone: A critical role of
the Smad signaling pathway. Biol Chem. 394:703–714. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Van Opdenbosch N and Lamkanfi M: Caspases
in cell death, inflammation, and disease. Immunity. 50:1352–1364.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yahara M, Tei K and Tamura M: Inhibition
of neuropeptide Y Y1 receptor induces osteoblast differentiation in
MC3T3-E1 cells. Mol Med Rep. 16:2779–2784. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tamura M, Sato MM and Nashimoto M:
Regulation of CXCL12 expression by canonical Wnt signaling in bone
marrow stromal cells. Int J Biochem Cell Biol. 43:760–767. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Montesano R, Pepper MS, Möhle-Steinlein U,
Risau W, Wagner EF and Orci L: Increased proteolytic activity is
responsible for the aberrant morphogenetic behavior of endothelial
cells expressing the middle T oncogene. Cell. 62:435–445. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsuji-Tamura K and Ogawa M: Dual
inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization
and impairs endothelial cell elongation. Biochem Biophys Res
Commun. 497:326–331. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakashima A, Katagiri T and Tamura M:
Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2)
signaling in differentiation pathway of C2C12 myoblasts. J Biol
Chem. 280:37660–37668. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iizuka S, Oridate N, Nashimoto M, Fukuda S
and Tamura M: Growth inhibition of head and neck squamous cell
carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE
gene silencing. PLoS One. 9:e1141212014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Nojima J, Kanomata K, Takada Y, Fukuda T,
Kokabu S, Ohte S, Takada T, Tsukui T, Yamamoto TS, Sasanuma H, et
al: Dual roles of smad proteins in the conversion from myoblasts to
osteoblastic cells by bone morphogenetic proteins. J Biol Chem.
285:15577–15586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Teixeira L, Sousa DM, Nunes AF, Sousa MM,
Herzog H and Lamghari M: NPY revealed as a critical modulator of
osteoblast function in vitro: New insights into the role of Y1 and
Y2 receptors. J Cell Biochem. 107:908–916. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Khor EC and Baldock P: The NPY system and
its neural and neuroendocrine regulation of bone. Curr Osteoporos
Rep. 10:160–168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kurebayashi N, Sato M, Fujisawa T,
Fukushima K and Tamura M: Regulation of neuropeptide Y Y1 receptor
expression by bone morphogenetic protein 2 in C2C12 myoblasts.
Biochem Biophys Res Commun. 439:506–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nikitovic D, Aggelidakis J, Young MF,
Iozzo RV, Karamanos NK and Tzanakakis GN: The biology of small
leucine-rich proteogly-cans in bone pathophysiology. J Biol Chem.
287:33926–33933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boskey AL, Spevak L, Doty SB and Rosenberg
L: Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on
hydroxyapatite formation in a gelatin gel. Calcif Tissue Int.
61:298–305. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou HY: Proteomic analysis of
hydroxyapatite interaction proteins in bone. Ann N Y Acad Sci.
1116:323–326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rehn AP, Chalk AM and Wendel M:
Differential regulation of osteoadherin (OSAD) by TGF-beta1 and
BMP-2. Biochem Biophys Res Commun. 349:1057–1064. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang SJ, Hoodless PA, Lu Z, Breitman ML,
McInnes RR, Wrana JL and Buchwald M: The Tlx-2 homeobox gene is a
downstream target of BMP signalling and is required for mouse
mesoderm development. Development. 125:1877–1887. 1998.PubMed/NCBI
|
|
32
|
Dennler S, Itoh S, Vivien D, ten Dijke P,
Huet S and Gauthier JM: Direct binding of Smad3 and Smad4 to
critical TGF beta-inducible elements in the promoter of human
plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091–3100.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zawel L, Dai JL, Buckhaults P, Zhou S,
Kinzler KW, Vogelstein B and Kern SE: Human Smad3 and Smad4 are
sequence-specific transcription activators. Mol Cell. 1:611–617.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schaefer L and Schaefer RM: Proteoglycans:
From structural compounds to signaling molecules. Cell Tissue Res.
339:237–246. 2010. View Article : Google Scholar
|
|
35
|
Weyers A, Yang B, Solakyildirim K, Yee V,
Li L, Zhang F and Linhardt RJ: Isolation of bovine corneal keratan
sulfate and its growth factor and morphogen binding. FEBS J.
280:2285–2293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Buraschi S, Neill T, Goyal A, Poluzzi C,
Smythies J, Owens RT, Schaefer L, Torres A and Iozzo RV: Decorin
causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci
USA. 110:E2582–E2591. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen CC and Lau LF: Functions and
mechanisms of action of CCN matricellular proteins. Int J Biochem
Cell Biol. 41:771–783. 2009. View Article : Google Scholar :
|
|
38
|
Kubota S and Takigawa M: Cellular and
molecular actions of CCN2/CTGF and its role under physiological and
pathological conditions. Clin Sci (Lond). 128:181–196. 2015.
View Article : Google Scholar
|
|
39
|
Hishikawa K, Oemar BS, Tanner FC, Nakaki
T, Fujii T and Lüscher TF: Overexpression of connective tissue
growth factor gene induces apoptosis in human aortic smooth muscle
cells. Circulation. 100:2108–2112. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hishikawa K, Oemar BS, Tanner FC, Nakaki
T, Lüscher TF and Fujii T: Connective tissue growth factor induces
apoptosis in human breast cancer cell line MCF-7. J Biol Chem.
274:37461–37466. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sakai Y, Balam TA, Kuroda S, Tamamura N,
Fukunaga T, Takigawa M and Takano-Yamamoto T: CTGF and apoptosis in
mouse osteocytes induced by tooth movement. J Dent Res. 88:345–350.
2009. View Article : Google Scholar : PubMed/NCBI
|
